Assessing six genes in 64 operable BC and 20 MBC patients as well as in 17 HD, Markou et al. detected CK19, ERBB2, MAGEA3, SCGB2A2 and TWISTP1 in 26.6%, 12.5%, 18.7%, 10.9% and 31.2% cases, respectively [46]. This evidence concerns the gene MAGEA3 and breast cancer.